1. Murayama A, Momose H, Yamada N, Matsubayashi K, Muramatsu M, Hamaguchi I, Kato T. Performance Evaluation of In Vitro Screening and Diagnostic Kits for Hepatitis C Virus Infection.Front Cell Infect Microbiol. 2022 Feb3;11:793472.doi:10.3389/fcimb.2021.793472.PMID: 35186779
2. Kusagawa S, Kawana-Tachikawa A, Matsubayashi K, Hoshi Y, Ishimaru K, and Hamaguchi I. Evaluation of Geenius HIV-1/2 Confirmatory Assay for the confirmatory and differential diagnosis of HIV-1/HIV-2 in Japan and reliability of the Geenius Reader in the diagnosis of HIV-2. BMC Infect Dis, 21(1):569, 2021
3. Kusagawa S, Tatsumi M, Sakamoto-Umeki Y, Takekawa N, Matsubayashi K, Ishimaru K, and Kawana-Tachikawa A. Nucleotide Sequence of HIV-1-Positive Specimen Reference Panel for Evaluation of HIV In Vitro Diagnostics in Japan. AIDS Res Hum Retroviruses, 37(12):994-997, 2021
4. Terada M, Kutsuna S, Togano T, Saito S, Kinoshita N, Shimanishi Y, Suzuki T, Miyazato Y, Inada M, Nakamoto T, Nomoto H, Ide S, Sato M, Maeda K, Matsunaga A, Satake M, Matsubayashi K, Tsuno H, Kojima M, Kuramistu M, Tezuka K, Ikebe E, Okuma K, Hamaguchi I, Shiratori K, Sato M, Kawakami Y, Inaba K, Igarashi S, Yamauchi R, Matsumura M, Ishimaru K, Cho H, Kuge C, Ishihara M, Gouda M, Tanaka K, Ishizaka Y, Ohmagari N, 2021, How we secured a COVID-19 Convalescent Plasma Procurement Scheme in Japan, Transfusion, Jun 7. doi: 10.1111/trf.16541
5. Kutusuna, Saito S, Takamatsu Y, Terada M, Togano T, Kinoshita N, Maeda K, Matsunaga A, Satake M, Matsubayashi K, Tsuno NH, Kojima M, Kuramistu M, Tezuka K, Ikebe E, Okuma K, Hamaguchi I, Shimanishi Y, Hangaishi A, Ishizaka Y, Ohmagari N, Mitsuya H, Safety of convalescent plasma therapy for COVID-19 patients and analysis of viral kinetics: a single-center, open-label, single-arm, interventional study in Japan, 2022, GHM Open, doi: 10.35772/ ghmo.2022.01002